MIRA · Mira Pharmaceuticals, Inc.
The AI's read
That separation could help distinguish MIRA-55 from common pain medicines. Earlier animal studies reported pain relief and reduced inflammation, including results compared with morphine and celecoxib. But no human results are reported, and the company is still preparing an application to begin human testing, targeted for the first half of 2027. The findings favor continued development, though they do not show whether the drug will work in people.